Selskabets formål er at fremme kommercialisering af nye ideer og forskningsresultater og start af nye innovative virksomheder gennem drift af forskerparker, incubatorer, konsulent- og rådgivningsvirksomhed samt øvrige beslægtede aktiviteter. Selskabet kan foretage kapitalindskud og eje kapitalandele i helt eller delvist ejede datterselskaber eller associerede selskaber, der driver virksomhed som ventureselskab eller anden lignende virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 108.6 mio. | -7 mio. | 705.3 mio. | 395.4 mio. | 42 | |
CVR: 10369703
Secondary names: KØBENHAVNS FORSKERPARK SYMBION A/S, KØBENHAVNS FORSKERBY SYMBION A/S, SYMBION SCIENCE PARK A/S
Previous names: ASX 10597 A/S, KØBENHAVNS FORSKERBY SYMBION EJENDOMSSELSKAB A/S
2 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 18.680 companies in Udlejning af erhvervsejendomme
Comparison is based on industry median values
Morten Frederiksen joined the board
Søren Hvidkjær left the board
Companies in the same industry and area
CVR 18646730
CVR 19104435
CVR 20126892
CVR 20126930
CVR 21118672
The financial health of SYMBION A/S shows signs of volatility, particularly with a significant loss of 6,961,000 DKK in 2024, following a profit of 3,193,000 DKK in 2023. Revenue has consistently increased over the past few years, rising from 70,915,000 DKK in 2020 to 108,636,000 DKK in 2024, indicating a strong growth trajectory. However, the decline in profitability raises concerns about operational efficiency and margin management. With equity standing at 395,399,000 DKK, the company maintains a solid capital base, but its recent losses may impact investor confidence and future funding opportunities within the commercial real estate rental sector.
AI-generated summary
companydata.dk